Raph blood group system

Area of Science:

• Transfusion Medicine
• Immunology
• Genetics

Background:

• The Raph blood group system comprises a single antigen, MER2.
• MER2 was reclassified in 2004 and is associated with the CD151 gene.
• CD151 protein is vital for cell interactions and signaling.

Purpose of the Study:

• To review the current knowledge of the Raph blood group system and the MER2 antigen.
• To explore the genetic basis and clinical implications of MER2 alloantibodies.
• To assess the significance of MER2 in transfusion medicine.

Main Methods:

• Literature review of reported cases of MER2 alloantibodies.
• Analysis of genetic mutations in the CD151 gene in affected individuals.
• Review of clinical phenotypes associated with CD151 gene variations.

Main Results:

• Six cases of human alloantibodies to MER2 have been reported.
• Three individuals with MER2 antibodies had stop codons in the CD151 gene, presenting with nephropathy, deafness, skin lesions, and P-thalassemia minor.
• Other individuals had missense mutations in CD151, with varying clinical presentations, including one case of hemolytic transfusion reaction.

Conclusions:

• Genetic variations in the CD151 gene are linked to MER2 alloantibodies and associated clinical conditions.
• While CD151 is important in cell biology, its clinical significance in transfusion medicine is currently limited.
• Further research is needed to fully understand the implications of the Raph blood group system in clinical practice.